Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-26

Clinical Trial Update: Switching Regimen in Treating Cirrhotic HCV GT1b Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating switching regimens for cirrhotic patients with chronic hepatitis C infection genotype 1b; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED